Activation of p53 in MDM2-overexpressing cells through phosphorylation

Biochemical and Biophysical Research Communications

Volumn 264, Issue 3, 1999, Pages 860-864

  Gao, Chongfeng ^b   Nakajima, Takuma ^b   Taya, Yoichi ^a   Tsuchida, Nobuo ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NONE

Author keywords

Apoptosis; BL2; MDM2; p53

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE INHIBITOR; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; PROTEASOME INHIBITOR; PROTEIN KINASE INHIBITOR; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; SERINE; UNCLASSIFIED DRUG; WORTMANNIN; Z VAD;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CONTROLLED STUDY; GENE ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RAJI CELL;

EID: 0033517821     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.1611     Document Type: Article

References (30)

1. Wu X. W., Bayle H., Olson D., Levine A. J. Genes Dev. 7:1993;1126-1132.
2. Haupt Y., Maya R., Kazaz A., Oren M. Nature. 387:1997;296-299.
3. Kubbutat M. G., Jones S. N., Vousden K. H. Nature. 1997;387-303.
4. Oliner J. D., Kinzler K. W., Geore D. L., Volgestein B. Nature. 358:1992;80-83.
5. Momand J., Jung D., Wilczynski S., Niland J. Nucleic Acids Res. 26:1998;3453-3459.
6. Reifenberger G., Liu L., Ichimura K., Schmidt E. E., Collins V. P. Cancer Res. 53:1993;2736-2739.
7. Capoulade C., Paillerets B. B., Lefrere I., Ronsin M., Feunteun J., Tursz T., Viels J. Oncogene. 16:1998;1603-1610.
8. Landers J. E., Cassel S. L., George D. L. Cancer Res. 57:1997;3562-3568.
9. Lowe S. W., Bodis S., McClatchey A., Remington L., Ruley H. E., Fisher D. E., Houseman D. E., Jack T. Science. 266:1994;807-810.
10. Lowe S. W., Ruley H. E., Jacks T., Houseman D. E. Cell. 74:1993;957-967.
11. Arriola E. L., Lopez A. R., Chresta C. M. Oncogene. 18:1999;1081-1091.
12. Shieh S.-Y., Ikeda M., Taya Y., Prives C. Cell. 91:1997;325-334.
13. Gao C. F., Tsuchida N. Jpn. J. Cancer Res. 90:1999;180-187.
14. Yamato K., Yamomoto M., Hirano Y., Tsuchida N. Oncogene. 11:1995;1-6.
15. Chen L., Marechal V., Moreau J., Levine A. J., Chen J. J. Biol. Chem. 272:1997;22966-22973.
16. Gervais J. L., Seth P., Zhang H. J. Biol. Chem. 273:1998;19207-19212.
17. Lee-Miller S. P., Sakaguchi K., Ullrich S. J., Appella E., Anderson C. W. Mol. Cell. Biol. 12:1992;5041-5048.
18. Banin S., Moyal L., Shieh S. Y., Taya Y., Anderson C. W., Chessa L., Smorodinsky N. I., Prives C., Reiss Y., Shiloh Y., Ziv Y. Science. 281:1998;1674-1677.
19. Canman C. E., Lim D., Cimprich K. A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M. B., Siliciano J. D. Science. 281:1998;1677-1679.
20. Tibbetts R. S., Brumbaugh K. M., Williams J. M., Sarkaria J. N., Cliby W. A., Shieh S., Taya Y., Prives C., Abraham R. T. Genes Dev. 13:1999;152-157.
21. Lambert P. F., Kashanchi F., Radonovich M. F., Shiekhattar R., Brady J. N. J. Biol. Chem. 273:1998;33048-33053.
22. Shieh S.-Y., Taya Y., Prives C. EMBO J. 18:1999;1815-1823.
23. Unger T., Juven-Gershon T., Moallem E., Berger M., Sionov R. V., Lozano G., Oren M., Haupt Y. EMBO J. 18:1999;1805-1814.
24. Lu H., Taya Y., Ikeda M., Levine A. J. Proc. Natl. Acad. Sci. USA. 95:1998;6399-6402.
25. Wang Y., Prives C. Nature. 376:1995;88-91.
26. Waterman M. J., Stavridi E. S., Waterman J. L., Halazonetis T. D. Nat. Genet. 19:1998;175-178.
27. Unger T., Sionov R. V., Moallem E., Yee C. L., Howley P. M., Oren M., Haupt Y. Oncogene. 18:1999;3205-3212.
28. Sarkaria J. N., Tibbetts R. S., Busby E. C., Kennedy A. P., Hill D. E., Abraham R. T. Cancer Res. 58:1999;4375-4382.
29. Knippschild U., Milne D. M., Campbell L. E., DeMaggio A. J., Christenson E., Hoekstra M. F., Meek D. W. Oncogene. 15:1997;1727-1736.
30. Ashcroft M., Kubbutat M. H. G., Vousden K. H. Mol. Cell. Biol. 19:1999;1751-1758.